| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Hughes Steven George is a Chief Medical Officer at VivoSim Labs, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $669K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sell | 2,373 | $72.23 | $171,401.79 | -6.1% | |
| Oct 22, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sale+OE | 2,209 | $47.54 | $105,014.53 | -5.4% | |
| Sep 22, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sale+OE | 2,208 | $40.58 | $89,600.64 | -5.4% | |
| Sep 15, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sale+OE | 1,542 | $45.41 | $70,022.22 | -3.8% | |
| Aug 22, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sale+OE | 2,208 | $46.40 | $102,461.58 | -5.4% | |
| Aug 13, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sale+OE | 1,542 | $46.66 | $71,949.72 | -3.8% | |
| Aug 6, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sale+OE | 81,434 | $42.74 | $3,480,269.29 | -19.8% | |
| Mar 20, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sell | 9,578 | $31.06 | $297,490.76 | -11.6% | |
| Jan 21, 2025 | RNA Avidity Biosciences, Inc. | Chief Medical Officer | Sell | 3,947 | $28.59 | $112,856.48 | -2.3% | |
| Aug 16, 2019 | VIVS Vivosim Labs, Inc. | Chief Medical Officer | Sell | 22,230 | $0.29 | $6,431.14 | -13.8% |